1. Home
  2. EXEL vs OVV Comparison

EXEL vs OVV Comparison

Compare EXEL & OVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • OVV
  • Stock Information
  • Founded
  • EXEL 1994
  • OVV 2020
  • Country
  • EXEL United States
  • OVV United States
  • Employees
  • EXEL N/A
  • OVV N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • OVV Oil & Gas Production
  • Sector
  • EXEL Health Care
  • OVV Energy
  • Exchange
  • EXEL Nasdaq
  • OVV Nasdaq
  • Market Cap
  • EXEL 9.8B
  • OVV 9.8B
  • IPO Year
  • EXEL 2000
  • OVV N/A
  • Fundamental
  • Price
  • EXEL $43.04
  • OVV $35.80
  • Analyst Decision
  • EXEL Buy
  • OVV Strong Buy
  • Analyst Count
  • EXEL 18
  • OVV 15
  • Target Price
  • EXEL $38.76
  • OVV $55.14
  • AVG Volume (30 Days)
  • EXEL 3.9M
  • OVV 4.6M
  • Earning Date
  • EXEL 05-13-2025
  • OVV 05-06-2025
  • Dividend Yield
  • EXEL N/A
  • OVV 3.35%
  • EPS Growth
  • EXEL 237.58
  • OVV N/A
  • EPS
  • EXEL 2.20
  • OVV 2.38
  • Revenue
  • EXEL $2,298,922,000.00
  • OVV $8,931,000,000.00
  • Revenue This Year
  • EXEL $10.39
  • OVV N/A
  • Revenue Next Year
  • EXEL $10.74
  • OVV N/A
  • P/E Ratio
  • EXEL $19.53
  • OVV $15.05
  • Revenue Growth
  • EXEL 24.49
  • OVV N/A
  • 52 Week Low
  • EXEL $20.40
  • OVV $29.80
  • 52 Week High
  • EXEL $48.85
  • OVV $51.72
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 59.93
  • OVV 47.27
  • Support Level
  • EXEL $42.21
  • OVV $34.88
  • Resistance Level
  • EXEL $43.75
  • OVV $37.20
  • Average True Range (ATR)
  • EXEL 1.60
  • OVV 1.03
  • MACD
  • EXEL -0.09
  • OVV -0.04
  • Stochastic Oscillator
  • EXEL 53.96
  • OVV 19.21

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About OVV Ovintiv Inc. (DE)

Ovintiv Inc is a North American oil and natural gas exploration and production company that is focused on developing its multi-basin portfolio of high-quality assets located in the United States and Canada. Its operations also include the marketing of oil, NGLs and natural gas. The company has two operating segments: USA Operations, and Canadian Operations. The USA Operations include the exploration for, development of, and production and marketing of oil, NGLs, natural gas and other related activities within the United States. The Canadian Operations include the exploration for, development of, and production and marketing of oil, NGLs, natural gas and other related activities within Canada.

Share on Social Networks: